DK2955518T4 - Demaskering af endotoxiner i opløsning - Google Patents

Demaskering af endotoxiner i opløsning Download PDF

Info

Publication number
DK2955518T4
DK2955518T4 DK14172151.4T DK14172151T DK2955518T4 DK 2955518 T4 DK2955518 T4 DK 2955518T4 DK 14172151 T DK14172151 T DK 14172151T DK 2955518 T4 DK2955518 T4 DK 2955518T4
Authority
DK
Denmark
Prior art keywords
unmasking
endotoxins
solution
Prior art date
Application number
DK14172151.4T
Other languages
English (en)
Other versions
DK2955518T3 (da
Inventor
Johannes Reich
Holger Grallert
Original Assignee
Biomerieux Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50897486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2955518(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomerieux Deutschland Gmbh filed Critical Biomerieux Deutschland Gmbh
Application granted granted Critical
Publication of DK2955518T3 publication Critical patent/DK2955518T3/da
Publication of DK2955518T4 publication Critical patent/DK2955518T4/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
DK14172151.4T 2014-06-12 2014-06-12 Demaskering af endotoxiner i opløsning DK2955518T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14172151.4A EP2955518B2 (en) 2014-06-12 2014-06-12 Unmasking endotoxins in solution

Publications (2)

Publication Number Publication Date
DK2955518T3 DK2955518T3 (da) 2019-08-19
DK2955518T4 true DK2955518T4 (da) 2022-04-25

Family

ID=50897486

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14172151.4T DK2955518T4 (da) 2014-06-12 2014-06-12 Demaskering af endotoxiner i opløsning
DK15727685.8T DK3155422T4 (da) 2014-06-12 2015-06-12 Demaskering af endotoksiner i opløsning

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK15727685.8T DK3155422T4 (da) 2014-06-12 2015-06-12 Demaskering af endotoksiner i opløsning

Country Status (13)

Country Link
US (4) US10697958B2 (da)
EP (5) EP2955518B2 (da)
JP (1) JP6566972B2 (da)
CN (3) CN110068692B (da)
AU (1) AU2015273432C1 (da)
CA (1) CA2951755C (da)
DK (2) DK2955518T4 (da)
ES (5) ES2736024T5 (da)
HU (1) HUE045617T2 (da)
PL (1) PL3155422T5 (da)
PT (1) PT3155422T (da)
SI (1) SI3155422T2 (da)
WO (1) WO2015189379A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2955518B2 (en) * 2014-06-12 2022-01-26 bioMérieux Deutschland GmbH Unmasking endotoxins in solution
EP3483609B1 (en) 2017-11-09 2022-01-05 Andreas Buchberger Method and kit for sample preparation and endotoxin determination
WO2021124267A1 (en) * 2019-12-20 2021-06-24 Pfizer Inc. Endotoxin detection

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB425216A (en) 1933-06-07 1935-03-07 Roderick Francis Hunwicke Improvements in or relating to a method of manufacturing bacterial solutions
US4276050A (en) * 1980-01-10 1981-06-30 Abbott Laboratories Method for systemic endotoxin detection
FR2614531A1 (fr) * 1987-04-29 1988-11-04 Martel Patrick Composition emolliente pour ongles
DK255887D0 (da) * 1987-05-20 1987-05-20 Claus Koch Immunoassay
US4808314A (en) * 1987-09-18 1989-02-28 Scripps Clinic And Research Foundation Method for reducing bacterial endotoxin contamination in solutions of macromolecules
US4909940A (en) 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
JPH07255462A (ja) 1994-02-02 1995-10-09 Agency Of Ind Science & Technol 有機溶媒耐性微生物の取得方法及び該方法により取得した有機溶媒耐性微生物
US5962428A (en) 1995-03-30 1999-10-05 Apollon, Inc. Compositions and methods for delivery of genetic material
US7276468B1 (en) * 1998-06-30 2007-10-02 Sandia Corporation Granulated decontamination formulations
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
IES20010042A2 (en) 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
JP2006512401A (ja) * 2001-06-05 2006-04-13 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ナノエマルジョンワクチン
ATE345502T1 (de) 2002-06-24 2006-12-15 Profos Ag Verfahren zum nachweis und zur entfernung von endotoxin
DE10306604A1 (de) * 2003-02-18 2004-08-26 Goldschmidt Ag Kosmetische Zubereitungen mit Wirkstoffen in Mikrokapseln
US20040202684A1 (en) * 2003-04-08 2004-10-14 David Djerassi Personalized interactive natural cosmetics
WO2005003152A1 (en) 2003-06-24 2005-01-13 Akzo Nobel N.V. Removal of lipopolysacchrarides from protein- lipopolysaccharide complexes by nonflammable solvents
DE10342289B3 (de) * 2003-09-12 2005-06-23 Detax Gmbh & Co. Kg Schaum zum Reinigen von Hörgeräten und Otoplastiken
DE10360844B4 (de) 2003-12-20 2007-05-16 Profos Ag Verfahren zum Nachweis und zur Entfernung von Endotoxin
DK1756136T3 (da) 2004-05-21 2015-01-19 Mo Bio Lab Inc Kit og fremgangsmåder til fjernelse af urenheder fra nukleinsyrer i miljø- og biologiske prøver
US7994138B2 (en) 2004-06-01 2011-08-09 Agscitech Inc. Microbial biosurfactants as agents for controlling pests
FR2875811B1 (fr) 2004-09-29 2008-08-22 Rhodia Chimie Sa Utilisation d'un alcool gras aliphatique dans les compositions moussantes detergentes pour l'entretien de surfaces dures ou textiles
JP2006194606A (ja) 2005-01-11 2006-07-27 Toray Ind Inc エンドトキシン活性の測定方法
KR20080016815A (ko) 2005-05-30 2008-02-22 다이이찌 산쿄 가부시키가이샤 엔도톡신 시험법
EP1917976B1 (en) 2005-08-01 2011-03-16 Hisamitsu Pharmaceutical Co. Inc. Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
US20080124248A1 (en) * 2006-11-29 2008-05-29 Edward Andrew Sobek Endotoxins and glucans quantification in indoor air
JP5270148B2 (ja) 2007-12-28 2013-08-21 花王株式会社 衣料用洗剤組成物
CA3081506A1 (en) 2008-03-05 2009-09-11 Genomatica, Inc. Long chain alcohol-producing organisms
CN102099465A (zh) * 2008-05-14 2011-06-15 海格罗斯投资有限责任公司 修饰的细胞内溶素Ply511
US9682173B2 (en) 2008-06-11 2017-06-20 The Children's Mercy Hospital Solutions for tissue engineering and methods of use
US9650405B2 (en) 2010-04-05 2017-05-16 SyntheZyme, LLC Modified sophorolipids as oil solubilizing agents
EP2386631A1 (en) * 2010-05-16 2011-11-16 Universiti Putra Malaysia Purified lipase, methods of modification and applications
CN103245785B (zh) * 2013-04-07 2014-12-17 四川科伦药业股份有限公司 一种细菌内毒素检测方法
SI3155424T1 (en) * 2014-06-12 2018-04-30 Hyglos Invest Gmbh Demonstration of endotoxins in the solution
EP2955518B2 (en) 2014-06-12 2022-01-26 bioMérieux Deutschland GmbH Unmasking endotoxins in solution

Also Published As

Publication number Publication date
JP2017519208A (ja) 2017-07-13
EP2955518B2 (en) 2022-01-26
EP3155422B2 (en) 2022-01-26
ES2878948T3 (es) 2021-11-19
EP3155422B1 (en) 2019-05-01
US20210018495A1 (en) 2021-01-21
PT3155422T (pt) 2019-07-29
EP3470840A1 (en) 2019-04-17
ES2738379T3 (es) 2020-01-22
EP3524981A1 (en) 2019-08-14
ES2738379T5 (es) 2022-07-01
AU2015273432C1 (en) 2019-01-17
CN110068692A (zh) 2019-07-30
EP2955518B1 (en) 2019-05-15
ES2879604T3 (es) 2021-11-22
US12099054B2 (en) 2024-09-24
US20190187131A1 (en) 2019-06-20
ES2736024T5 (es) 2022-07-01
EP3524981B1 (en) 2021-03-03
PL3155422T3 (pl) 2019-10-31
CN107076765A (zh) 2017-08-18
ES2736024T3 (es) 2019-12-23
CA2951755A1 (en) 2015-12-17
US20170131265A1 (en) 2017-05-11
US10697958B2 (en) 2020-06-30
SI3155422T1 (sl) 2019-08-30
EP3155422A1 (en) 2017-04-19
CN107076765B (zh) 2019-09-13
US11860158B2 (en) 2024-01-02
JP6566972B2 (ja) 2019-08-28
AU2015273432A1 (en) 2016-12-22
DK3155422T4 (da) 2022-02-07
EP3848707A1 (en) 2021-07-14
DK2955518T3 (da) 2019-08-19
SI3155422T2 (sl) 2022-04-29
CN110068692B (zh) 2023-04-14
AU2015273432B2 (en) 2018-08-16
EP2955518A1 (en) 2015-12-16
WO2015189379A1 (en) 2015-12-17
DK3155422T3 (da) 2019-07-15
EP3470840B1 (en) 2021-03-03
US20190353648A1 (en) 2019-11-21
CA2951755C (en) 2020-04-14
PL3155422T5 (pl) 2023-01-30
ES2971739T3 (es) 2024-06-06
EP3848707B1 (en) 2023-12-27
HUE045617T2 (hu) 2020-01-28
CN110470850A (zh) 2019-11-19

Similar Documents

Publication Publication Date Title
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3556777T3 (da) Multispecifikke antistofkonstrukter
DK3193931T3 (da) Neutralisering af hæmmende veje i lymfocytter
DK3134530T3 (da) Behandling af hyperbilirubinæmi
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3183272T3 (da) Asymmetriske multispecifikke antistoffer
DK3126395T3 (da) Multispecifikke antistoffer
DK3132034T3 (da) Terapeutikum
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3094974T3 (da) Identifikation af funktionelle cellers tilstande
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3166911T3 (da) Inkorporering af biologiske midler i gødning
DK3307267T3 (da) Behandling af multipel sklerose
DK3296597T3 (da) Krydshovedmotor
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3511000T3 (da) Krystallinsk form x2 af grapiprant
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK3294893T3 (da) Bioproduktion af lentivirale vektorer
DK3183362T3 (da) Elektrokemisk detektering af mikroorganismer
DK3418273T3 (da) Derivater af flavagliner
DK3289363T3 (da) Specifik påvisning af clusterin isoformer
DK3018383T3 (da) Afslutning af styrkeelementer i dybhavskabler
DK3155422T4 (da) Demaskering af endotoksiner i opløsning
DK3173071T3 (da) Formularing af maropitant
DK3200783T3 (da) Behandling af erytromelalgi